Arnt Schellekens

Martial LC, Aarnoutse RE, Mulder M, Schellekens A, Brüggemann RJM, Burger DM, Schene AH, Batalla A.  2017.  Dried Blood Spot sampling in psychiatry: Perspectives for improving therapeutic drug monitoring.. Eur Neuropsychopharmacol. 27(3):205-216.

Batalla A, Homberg JR, Lipina TV, Sescousse G, Luijten M, Ivanova SA, Schellekens A, Loonen AJM.  2017.  The role of the habenula in the transition from reward to misery in substance use and mood disorders.. Neurosci Biobehav Rev.

Ayu AParawita, Iskandar S, Siste K, DeJong CA, Schellekens A.  2016.  Addiction training for health professionals as an antidote to the addiction health burden in Indonesia.. Addiction. 111(8):1498-9.

Kamal RM, Schellekens A, DeJong CA, Dijkstra BAG.  2015.  Baclofen as relapse prevention in the treatment of Gamma- Hydroxybutyrate (GHB) dependence: an open label study.. BMC Psychiatry. 15:91.

Ayu AParawita, Schellekens A, Iskandar S, Pinxten L, DeJong CA.  2015.  The development of an National Training Program on Addiction Medicine in Indonesia. el-Guebaly N, Carrà G, Galanter M (Eds) Textbook of Addiction Treatment: International Perspectives. XII

Paling E.P., Dijkstra BAG, DeJong CA, Schellekens A.  2015.  Prevalentie en behandeling van benzodiazepineverslaving. Tijdschrift Gedragstherapie. 48(2):185-198.

Schellekens A, DeJong CA, Buitelaar JK, Verkes RJ.  2014.  Co-morbid anxiety disorders predict early relapse after inpatient alcohol treatment.. Eur Psychiatry.

van Oene GH de Weert, Schellekens A, Dijkstra BAG, Kamal RM, DeJong CA.  2013.  Detoxification of patients with GHB dependence.. Tijdschr Psychiatr. 55(11):885-90.

Istriana E, Kurnia A, Weijers A, Hidayat T, Pinxten L, DeJong CA, Schellekens A.  2013.  Excellent reliability of the Hamilton Depression Rating Scale (HDRS-21) in Indonesia after training.. Asia Pac Psychiatry.

de Haan HA, Joosten EAG, de Haan L, Schellekens A, Buitelaar JK, van der Palen J, DeJong CA.  2013.  A family history of alcoholism relates to alexithymia in substance use disorder patients.. Compr Psychiatry.

Schellekens A, Franke B, Ellenbroek B, Cools AR, DeJong CA, Buitelaar JK, Verkes RJ.  2012.  COMT Val158Met modulates the effect of childhood adverse experiences on the risk of alcohol dependence.. Addict Biol.

Schellekens A, Mulders PCR, Ellenbroek B, DeJong CA, Buitelaar JK, Cools AR, Verkes RJ.  2012.  Early-onset alcohol dependence increases the acoustic startle reflex.. Alcohol Clin Exp Res. 36(6):1075-83.

van der Schaaf ME, van Schouwenburg MR, Geurts DEM, Schellekens A, Buitelaar JK, Verkes RJ, Cools AR.  2012.  Establishing the Dopamine Dependency of Human Striatal Signals During Reward and Punishment Reversal Learning.. Cereb Cortex.

de Haan HA, Schellekens A, van der Palen J, Verkes RJ, Buitelaar JK, DeJong CA.  2012.  The level of alexithymia in alcohol-dependent patients does not influence outcomes after inpatient treatment.. Am J Drug Alcohol Abuse. 38(4):299-304.

Schellekens A, Franke B, Ellenbroek B, Cools AR, DeJong CA, Buitelaar JK, Verkes RJ.  2012.  Reduced dopamine receptor sensitivity as an intermediate phenotype in alcohol dependence and the role of the COMT Val158Met and DRD2 Taq1A genotypes.. Arch Gen Psychiatry. 69(4):339-48.

Schellekens A, Mulder SF, van Eijndhoven PFP, Smilde TJ, van Herpen CML.  2011.  Psychotic symptoms in the course of sunitinib treatment for advanced renal cell cancer. Two cases.. Gen Hosp Psychiatry. 33(1):83.e1-3.

Schellekens A, de Bruijn ERA, van Lankveld CAA, Hulstijn W, Buitelaar JK, DeJong CA, Verkes RJ.  2010.  Alcohol dependence and anxiety increase error-related brain activity.. Addiction. 105(11):1928-34.

Schellekens A, Grootens KP, Neef C, Movig KLL, Buitelaar JK, Ellenbroek B, Verkes RJ.  2010.  Effect of apomorphine on cognitive performance and sensorimotor gating in humans.. Psychopharmacology (Berl). 207(4):559-69.

Schellekens A, van Oosterwijck AWAA, Ellenbroek B, DeJong CA, Buitelaar JK, Cools AR, Verkes RJ.  2009.  The dopamine agonist apomorphine differentially affects cognitive performance in alcohol dependent patients and healthy controls.. Eur Neuropsychopharmacol. 19(1):68-73.

Schellekens A, van Oosterwijck AWAA, Ellenbroek B, DeJong CA, Buitelaar JK, Cools AR, Verkes RJ.  2009.  The dopamine agonist apomorphine differentially affects cognitive performance in alcohol dependent patients and healthy controls. Eur Neuropsychopharmacol. 1(19):73.

Schellekens A, Kramer R, Vander Moolen A, Dumondt G, DeJong CA.  2009.  Neurofarmacologie van alcohol, cannabis, opiaten, cocaïne en nicotine. Verslavingsgeneeskunde: Psychofarmacologie, psychiatrie en somatiek.

van der Linden D, Massar SAA, Schellekens A, Ellenbroek B, Verkes RJ.  2006.  Disrupted sensorimotor gating due to mental fatigue: preliminary evidence.. Int J Psychophysiol. 62(1):168-74.